Ryan Savitz
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $14.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 10,35420,895 held (−33%) | $100.22 | $1.0M | -17.8% |
| Jul 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 15,3295,566 held (−73%) | $101.24 | $1.6M | -18.6% |
| Jul 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 5,566 | $101.97 | $568K | -19.2% |
| Apr 10SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 8,224 | $89.84 | $739K | -8.3% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 1,390112,977 held (−1%) | $78.33 | $109K | +5.2% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 21,82591,152 held (−19%) | $78.86 | $1.7M | +4.5% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 1,48589,667 held (−2%) | $80.25 | $119K | +2.6% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 80088,867 held (−1%) | $81.36 | $65K | +1.2% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 2,36686,501 held (−3%) | $82.84 | $196K | -0.6% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 59,80026,701 held (−69%) | $83.90 | $5.0M | -1.8% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 19,4697,232 held (−73%) | $84.57 | $1.6M | -2.6% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 7,232 | $85.54 | $619K | -3.7% |
| Dec 5SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 20,000 | $45.18 | $904K | +82.3% |
- Sell
CFO Ryan Savitz sold $1.0M of DNTH at $100.22 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ryan Savitz sold $1.6M of DNTH at $101.24 — cuts the stake by 73%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ryan Savitz sold $568K of DNTH at $101.97 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ryan Savitz sold $739K of DNTH at $89.84 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ryan Savitz sold $109K of DNTH at $78.33 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ryan Savitz sold $1.7M of DNTH at $78.86 — pre-scheduled 10b5-1 plan sale.